Pier Capital, LLC Halozyme Therapeutics, Inc. Transaction History
Pier Capital, LLC
- $714 Million
- Q1 2024
A detailed history of Pier Capital, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Pier Capital, LLC holds 222,632 shares of HALO stock, worth $11.7 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
222,632
Previous 129,479
71.94%
Holding current value
$11.7 Million
Previous $4.79 Million
89.26%
% of portfolio
1.27%
Previous 0.7%
Shares
7 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$959 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$686 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$341 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$216 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$199 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.32B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...